6.JPG)
The Global Smart Pill Technology Market Size is valued at USD 4.22 billion in 2023 and is predicted to reach USD 9.21 billion by the year 2031 at a 10.55% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- An increase in colon cancer cases, a rise in the demand for noninvasive monitoring and diagnostic tools, and developments in capsule endoscopy are the main factors supporting the growth of the smart pill market.
- The market is being propelled even further by the rise in research and development spending on smart pill development.
- North America dominated the market and accounted for a revenue share of global revenue in 2023.
- The rising price of the ingestible sensors and the anticipated stringent government rules on their usage will likely put a damper on the market.
By bridging the gap between digital technology and healthcare, smart pill technologies have sparked a new wave of change in the healthcare sector. Digital ingestible pills containing edible electronic sensors are known as "smart pills." Investment levels in the market for smart pill technologies are rising quickly. Many investors are drawn to smart pill technologies due to their growing appeal among a sizable portion of the world's population. In mergers, acquisitions, and startups, numerous businesses and investment firms make significant investments. These elements could contribute to the market for smart pill technology growing more quickly. Among these are smart medicines. To expand their customer base, the market participants for smart pill technologies make significant investments in R&D efforts.
Moreover, the leading market growth drivers are the participants improved reimbursement rates and more superficial regulatory approvals for capsule endoscopy. The desire of patients to choose this treatment, ease of monitoring body processes and managing medicines, and general health are the main market drivers. However, factors offering a hurdle to the smart pill technology market growth include probable health hazards related to a smart pill being introduced into the body, privacy concerns, and ethical considerations.
Market Segmentation:
The smart pill technology market is segmented on the application, target area, disease indication and end users. Based on application, the market is divided into capsule endoscopy, drug delivery and patient monitoring. Based on the target area, the smart pill technology market is segmented into the esophagus, stomach, and small and large intestines. Based on the disease indication, the smart pill technology market is segmented into barrett's esophagus, small bowel diseases, colon cancer and others. Based on end-use, the smart pill technology market is segmented into hospitals, clinics, diagnostic centers, and research centers.
Based on application, the capsule endoscopy segment is a major contributor to the smart pill technology market.
The market's leading segment is capsule endoscopy. It is anticipated that factors like wireless health monitoring and site-specific drug delivery will encourage both patients and doctors to use these technologies. A procedure called capsule endoscopy—called GI capsule, camera capsule, pill camera, or wireless end capsule—is employed to diagnose GI diseases. Devices for capsule endoscopy consist of four microcapsules: a light source, a color camera, a transmitter, and a battery. A lot of flexibility is available with capsule endoscopy. Both wireless patient monitoring and intelligent drug delivery (also known as Bio-MEMS drug delivery system) via smart pills are still in their infancy.
The hospital and clinics segment witnessed growth at a rapid rate.
Hospitals and clinics grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time. The way that patients are treated in hospitals has changed noticeably. In the comfort of a patient's sensor, embedded systems or diagnostic tools support monitoring vital signs, including temperature, pH, pulse, and others. The ability to integrate sensors and electronics at lower power levels on materials like silicon is growing. This improves the multiple drug delivery applications for sensors. As a result, the market for hospitals and clinics is expanding, creating new opportunities for the smart pill market to expand.
The North American smart pill technology market holds a significant regional revenue share.
North America is anticipated to post respectable gains during the study period. Medical researchers' ongoing progress in the area of ingestible electronics is what is fueling this rise. The U.S. FDA and other regional agencies have been developing standards for obtaining digital smart tablet approval. In addition, the rise in colorectal cancer incidence, improvements in healthcare technology, and the regulatory clearance of new products. All these variables are anticipated to present growth prospects for the players operating in this region. Besides, Asia-Pacific smart pill market share would grow more quickly than any other region. Because of the growing older population, rising healthcare spending, and advancements in medical technology.
Recent Developments:
- In January 2024, etectRx, Inc. (etectRx) reported that the number of ingestions of its ID-Cap System digital pill has exceeded 10,000. This is a big deal for the company, which has a reputation for providing data to track patient's adherence to their oral medications accurately and has shown strong results.
- In November 2023, Check-Cap Ltd. announced that ISS, a prominent independent proxy advisory firm, has advised that at the forthcoming Annual General Meeting of Shareholders.
- In January 2024, AnX Robotica is pleased to announce that NaviCam ProScanTM has received FDA clearance. The company is a leader in cutting-edge gastrointestinal visualization technologies. After passing the FDA's stringent De Novo Submission Process, ProScan is now the first artificial intelligence-assisted reading tool specifically developed to assist reviewers of small intestine capsule endoscopy images taken of adults with suspicion of small intestinal bleeding.
Competitive Landscape
Some major key players in the Global Smart Pill Technology Market:
- RF Co., Ltd,
- JINSHAN Science and Technology,
- Proteus Digital Health,
- HQ, Inc.,
- CapsoVision, Inc.,
- Medtronic Plc.,
- Olympus Corporations,
- IntroMedic Co., Ltd,
- Check Cap,
- Koninklijke Philips N.V.
Global Smart Pill Technology Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 4.22 billion |
|
Revenue Forecast In 2031 |
USD 9.21 billion |
|
Growth rate CAGR |
CAGR of 10.55% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Application, Target Area, Disease Indication, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
RF Co., Ltd, JINSHAN Science and Technology, Proteus Digital Health, HQ, Inc., CapsoVision, Inc., Medtronic Plc., Olympus Corporations, IntroMedic Co., Ltd, Check Cap, Koninklijke Philips N.V. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
